Betul A. Sin
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The long-term effectiveness of specific immunotherapy in cat allergy: a real-life study.
Journal: Immunotherapy
Published: July 13, 2026
Control Status of Chronic Rhinosinusitis in Severe Asthma Patients Receiving Biologics: A Real-World Cross-Sectional Study.
Journal: The Annals of otology, rhinology, and laryngology
Published: April 02, 2026
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis.
Journal: Allergy and asthma proceedings
Published: July 08, 2025
Benralizumab in severe eosinophilic asthma: A real-life data from Türkiye.
Journal: Respiratory medicine
Published: June 28, 2025
Impact of patient education meetings on disease knowledge in chronic urticaria patients.
Journal: Turkish journal of medical sciences
Published: February 24, 2025
Factors Affecting the Safety and Effectiveness of Venom Immunotherapy.
Journal: Journal of investigational allergology & clinical immunology
Published: November 08, 2023
Apples and pears serve the same purpose: Better diagnosis for anaphylaxis.
Journal: The World Allergy Organization journal
Published: September 01, 2023
What happens to basophils and tryptase, LXA4 and CysLTs during aspirin desensitization?
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: December 06, 2022
Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience.
Journal: Tuberkuloz ve toraks
Published: September 27, 2022
Comparison of two diagnostic criteria in the diagnosis of anaphylaxis in a tertiary adult allergy clinic.
Journal: The World Allergy Organization journal
Published: September 07, 2022
Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?
Journal: European annals of allergy and clinical immunology
Published: July 19, 2022
Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
Journal: International archives of allergy and immunology
Published: July 06, 2022
Last Updated: 09/26/2026